ArticleThe Journal of infectious diseases2013

Targeting of the purine biosynthesis host cell pathway enhances the activity of tenofovir against sensitive and drug-resistant HIV-1.

Alonso Heredia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.